Intellectual Property Patents

2017

COMPOSITIONS AND METHODS FOR CANCER TREATMENT
Application No. PCT/CA2017/050768
Patent Status: Granted/Issued
Year Issued: June 22, 2017
Inventors: William W. Harless, M.D., Ph.D. and CEO Encyt Technologies, Inc. and Myron R Szewczuk, Ph.D.
Agent: NORTON ROSE FULBRIGHT CANADA LLP, 1 Place Ville Marie, Suite 2500, Montreal, Quebec H3B lRl, Canada
Canadian Intellectual Property Office (RO/CA)

METHOD TO IMPROVE THE EFFECTIVENESS OF ANTI-CANCER THERAPIES BY EXPOSING CANCER CELLS TO AN INFLAMMATORY STIMULUS PRIOR TO TREATMENT
Application No. PCT/CA2017/ 050765
Patent Status: Granted/Issued
Year Issued: June 22, 2017
Inventors: William W. Harless, M.D., Ph.D. and CEO Encyt Technologies, Inc. and Myron R Szewczuk, Ph.D.
Agent: NORTON ROSE FULBRIGHT CANADA LLP, 1 Place Ville Marie, Suite 2500,Montreal, Quebec H3B lRl, Canada
Canadian Intellectual Property Office (RO/CA)

2014

Use of Neu1 Sialidase Inhibitors in the Treatment of Cancer.
Patent Application based on PCT/CA2011/050690. 2014/07/07.
Patent Status: Granted/Issued
Year Issued: 2014
Canada Patent

Use of Neu1 Sialidase Inhibitors in the Treatment of Cancer.
Application No. 11874886.2. 2014/07/07.
Patent Status: Granted/Issued - Application No./Patent No. 11874886.2 - 1112 / 2773340
Year Issued: 2014
European Patent

Use of Neu1 Sialidase Inhibitors in the Treatment of Cancer.
Patent Application based on PCT/CA2011/050690. 2014/07/07.
Patent Status: Granted/Issued
Year Issued: 2014
Chinese Patent

Use of Neu1 Sialidase Inhibitors in the Treatment of Cancer
Patent Application No. 14/370,916. 2014/07/07.
Patent Status: Granted/Issued - Pub. No.: US 2015/0064282 A1
Year Issued: 2014
United States Patent

2011

USE OF OSELTAMIVIR PHOSPHATE AND ANALOGUES THEREOF FOR THE TREATMENT OF CANCER
Inventors: Myron R. Szewczuk, Ph.D. and Paul Josefowitz
Filing Serial No.: PCT/CA2011/050690, November 04, 2011
International Patent Cooperation Treaty (PCT)

1987-1993

Method for treating cancer with alternating 60 Hertz non-ionizing magnetic fields.
Inventors: Myron R. Szewczuk, Ph.D., William C. Morris, B.Sc. and John C. Beal, Ph.D. 
Filing Serial No.: February 16, 1993.
UNITED STATES PATENT

HIV Marker/ AIDS Vaccine
Inventors: Myron R. Szewczuk, Ph.D., Rashid H. Khan, M.D., Ph.D. and Douglas K. MacFadden, M.D., Ph.D. 
Filing Serial No.: November 19, 1990.
International Patent Cooperation Treaty (PCT)

Method for evaluating effective immunity against HIV infection and spread
Inventors: Myron R. Szewczuk, Ph.D., Rashid H. Khan, M.D., Ph.D. and Douglas K. MacFadden, M.D., Ph.D. 
Filing Serial No.: Canada; November 14, 1990; U.S.A.; November 14, 1990; February 9, 1993
Canada and United States Patents

Method for evaluating protection to bee venom.
Inventors: Myron R. Szewczuk, Ph.D., Rashid H. Khan, M.D., Ph.D. and James H. Day, M.D.
Filing Serial No.: 2,002,811-4; Canada; Nov 10, 1989, 442,910; U.S.A.; Nov 28, 1989.
UNITED STATES PATENT: Patent Number - 5,124,249, Date of patent - June 23, 1992